New liver transplant rules may drive up costs, study finds

NCT ID NCT05087550

Completed Knowledge-focused Sponsor: Methodist Health System Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how a new U.S. policy for distributing donated livers (started in 2020) affected costs for liver transplants at one hospital in Dallas. Researchers compared costs and transplant volumes for 186 patients before and after the policy change. The goal was to understand if the new rules, which aim to give organs to the sickest patients first, also lead to higher expenses for hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help hospitals and policymakers understand the financial impact of new organ allocation rules, potentially leading to more cost-effective transplant systems.
What could go wrong: This is a small, single-center study that only looks at costs, not patient outcomes. The findings may not apply to other hospitals or regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic liver failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER TRANSPLANT

Contacts and locations

Locations

The Liver Institute at Methodist Dallas Medical Center

Dallas, Texas, 75203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.